@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@o 30344 ŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞ @@@Ęí[hÉßé@@Ť@@hmcdw@@Ť@@áOÖ@@ @@Öâ@@@ ŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞŞ @ĽK y {uz tp Franbvksow 21/1/6( ) 14:50 @ @Ąčź F K y {uz tp @ĄźO F Franbvksow <dermowe@hrunopot.com> @Ąút F 21/1/6( ) 14:50 @Ąv F https://onko-pharma.kz @-------------------------------------------------------------------------
B y~u~u-pu{u }w~ xp{pxp ~|pz~ @rpy~ (Avastin) ~uts p}z t
~z u~u r Kpxpp~u r {pxpp~u { y {pq|py~ { y r {pxpp~u {pq|py~ urp 150 |u~ry}p y~ {y y}u~u~y pp~ { y y}q ry{p u~p r q| [url=https://onko-pharma.kz]ofatumumab u~p[/url] [url=https://onko-pharma.kz]ruxolitinib u~p[/url] [url=https://onko-pharma.kz]{p|yrp u~p[/url] [url=https://onko-pharma.kz]~{up qurpx }pq {|{ y[/url] [url=https://onko-pharma.kz] u~ xr[/url] |